Jürgen Geisler

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree et al. · European Heart Journal · 2016 · 661 citations · Full text

Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Jürgen Geisler, Ben P. Haynes, Gun Anker et al. · Journal of Clinical Oncology · 2002 · 573 citations

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

Jürgen Geisler, Nicholas King, Mitch Dowsett et al. · British Journal of Cancer · 1996 · 341 citations · Full text

Breast Oncology, Oncology, Medicine +11

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Jürgen Geisler, Nicholas King, Gun Anker et al. · PubMed · 1998 · 316 citations

Bolus Injection, Breast Oncology, Gynecology +17

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Per Eystein Lønning, Jürgen Geisler, Lars Erik Krag et al. · Journal of Clinical Oncology · 2005 · 293 citations · Full text